{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:06:16Z","timestamp":1792800376163,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Outstanding Youth Fund of The Natural Science Foundation of Guangxi in China","award":["2023GXNSFFA026007"],"award-info":[{"award-number":["2023GXNSFFA026007"]}]},{"name":"The Outstanding Youth Fund of The Natural Science Foundation of Guangxi in China","award":["2023GXNSFFA026007"],"award-info":[{"award-number":["2023GXNSFFA026007"]}]},{"name":"the Self-funded Scientific Research Project by the Health Commission of Guangxi Zhuang Autonomous Region","award":["Z-A20240621"],"award-info":[{"award-number":["Z-A20240621"]}],"id":[{"id":"https:\/\/ror.org\/01x9sys47","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response","award":["GKLKP-KF-202202"],"award-info":[{"award-number":["GKLKP-KF-202202"]}]},{"name":"the Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response","award":["GKLKP-KF-202202"],"award-info":[{"award-number":["GKLKP-KF-202202"]}]},{"name":"the Guangxi Key Research and Development Project","award":["Guike AB24010175"],"award-info":[{"award-number":["Guike AB24010175"]}]},{"name":"the General Program of the Natural Science Foundation of Guangxi in China","award":["2023GXNSFAA026287"],"award-info":[{"award-number":["2023GXNSFAA026287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25232-4","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:37:57Z","timestamp":1763401077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transition from HIV post-exposure prophylaxis to pre-exposure prophylaxis and awareness-to-use cascade among men who have sex with men: a longitudinal study in Guangxi, China"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7675-9932","authenticated-orcid":false,"given":"Yun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8748-2780","authenticated-orcid":false,"given":"Chuanyi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"25232_CR1","doi-asserted-by":"crossref","unstructured":"Baeten J, Celum C. Oral antiretroviral chemoprophylaxis: current status. Curr Opin HIV AIDS. 2012;7(6):514\u20139.","DOI":"10.1097\/COH.0b013e3283582d30"},{"key":"25232_CR2","doi-asserted-by":"crossref","unstructured":"Portman M. Pre-exposure prophylaxis: making history. Sex Transm Infect. 2017;93(1):7.","DOI":"10.1136\/sextrans-2016-053059"},{"key":"25232_CR3","doi-asserted-by":"crossref","unstructured":"Walensky RP, Baden LR. The Real PURPOSE of PrEP - Effectiveness, Not Efficacy. N Engl J Med. 2024;391(13):1246-7.","DOI":"10.1056\/NEJMe2408591"},{"key":"25232_CR4","doi-asserted-by":"crossref","unstructured":"Armishaw J, Hoy JF, Watson KM, Wright EJ, Price BG, Pierce AB. Non-occupational post-exposure prophylaxis in Victoria, Australia: responding to high rates of re-presentation and low rates of follow-up. Int J STD AIDS. 2011;22(12):714\u20138.","DOI":"10.1258\/ijsa.2011.011174"},{"key":"25232_CR5","doi-asserted-by":"crossref","unstructured":"Wong K, Hughes CA, Plitt S, Foisy M, MacDonald J, Johnson M, et al. HIV non-occupational postexposure prophylaxis in a Canadian province: treatment completion and follow-up testing. Int J STD AIDS. 2010;21(9):617\u201321.","DOI":"10.1258\/ijsa.2008.008482"},{"issue":"10013","key":"25232_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet"},{"key":"25232_CR7","doi-asserted-by":"crossref","unstructured":"Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for disease control and prevention needlestick surveillance group. N Engl J Med. 1997;337(21):1485\u201390.","DOI":"10.1056\/NEJM199711203372101"},{"issue":"5","key":"25232_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/apc.2019.0313","volume":"34","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yuan T, Fan S, Qian HZ, Li P, Zhan Y, et al. HIV nonoccupational postexposure prophylaxis among men who have sex with men: a systematic review and meta-analysis of global data. AIDS Patient Care STDS. 2020;34(5):193\u2013204.","journal-title":"AIDS Patient Care STDS"},{"key":"25232_CR9","doi-asserted-by":"crossref","unstructured":"Wang X, Xu J, Wu Z. A pilot program of pre-exposure and post-exposure prophylaxis promotion among men who have sex with men \u2013\u20097 study sites, China, 2018\u20132019. China CDC Wkly. 2020;2(48):917\u20139.","DOI":"10.46234\/ccdcw2020.250"},{"key":"25232_CR10","unstructured":"National Center for AIDS\/STD Control and Prevention. Chinese Guideline on HIV PEP. 2020. https:\/\/ncaids.chinacdc.cn\/xxgx\/jszl\/202011\/W020201116802422550750.pdf. Accessed 8 Oct 2024."},{"key":"25232_CR11","unstructured":"Xu J, Huang X, Liu X, Wang L, Chen Y, Wang H et al. Chinese expert consensus on HIV pre-exposure prophylaxis. Chin J AIDS STD. 26(11):1265\u201371."},{"key":"25232_CR12","unstructured":"Zhang L, Wang H. Chinese expert consensus on HIV pre-exposure prophylaxis (2023 version). Chin J AIDS STD. 29(09):954\u201361."},{"issue":"7","key":"25232_CR13","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1016\/S2352-3018(22)00138-2","volume":"9","author":"H Wang","year":"2022","unstructured":"Wang H, Tang W, Shang H. Expansion of PrEP and PEP services in China. Lancet HIV. 2022;9(7):e455-457.","journal-title":"Lancet HIV"},{"key":"25232_CR14","unstructured":"CDC. Pre-Exposure Prophylaxis (PrEP). 2022. https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html. Accessed 8 Oct 2024."},{"key":"25232_CR15","unstructured":"WHO. Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery and Monitoring: Recommendations for a Public Health Approach. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240031593. Accessed 8 Oct 2024."},{"issue":"1","key":"25232_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21485-w","volume":"12","author":"F Hovaguimian","year":"2021","unstructured":"Hovaguimian F, G\u00fcnthard HF, Hauser C, Conen A, Bernasconi E, Calmy A, et al. Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis. Nat Commun. 2021;12(1):1219.","journal-title":"Nat Commun"},{"issue":"Suppl 3","key":"25232_CR17","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/civ094","volume":"60","author":"S Jain","year":"2015","unstructured":"Jain S, Krakower DS, Mayer KH. The transition from postexposure prophylaxis to preexposure prophylaxis: an emerging opportunity for biobehavioral HIV prevention. Clin Infect Dis. 2015;60(Suppl 3):S200-204.","journal-title":"Clin Infect Dis"},{"key":"25232_CR18","doi-asserted-by":"crossref","unstructured":"Siemieniuk RA, Sivachandran N, Murphy P, Sharp A, Walach C, Placido T, et al. Transitioning to HIV pre-exposure prophylaxis (PrEP) from non-occupational post-exposure prophylaxis (nPEP) in a comprehensive HIV prevention clinic: a prospective cohort study. AIDS Patient Care STDS. 2015;29(8):431\u20136.","DOI":"10.1089\/apc.2015.0014"},{"key":"25232_CR19","unstructured":"CDC. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States \u2013. 2021 Update. 2021. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2021.pdf. Accessed 8 Oct 2024."},{"key":"25232_CR20","doi-asserted-by":"crossref","unstructured":"Yang X, Jiang L, Fang T, Huang J, Tan S, Lu C, et al. Individual and network factors associated with HIV self-testing among men who have sex with men in resource-limited settings in China. Sex Health. 2022;19(3):212\u201323.","DOI":"10.1071\/SH21133"},{"key":"25232_CR21","doi-asserted-by":"crossref","unstructured":"Richardson D, Nichols K, Pickering A, Devlin J, Buss Z, Fitzpatrick C, et al. Transitioning from HIV post-exposure prophylaxis to pre-exposure prophylaxis in men who have sex with men. HIV Med. 2021;22(8):780\u20131.","DOI":"10.1111\/hiv.13112"},{"key":"25232_CR22","doi-asserted-by":"crossref","unstructured":"Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the international antiviral Society-USA panel. JAMA. 2020;324(16):1651\u201369.","DOI":"10.1001\/jama.2020.17025"},{"issue":"6","key":"25232_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25670","volume":"24","author":"J Ayieko","year":"2021","unstructured":"Ayieko J, Petersen ML, Kabami J, Mwangwa F, Opel F, Nyabuti M, et al. Uptake and outcomes of a novel community-based HIV post-exposure prophylaxis (PEP) programme in rural Kenya and Uganda. J Int AIDS Soc. 2021;24(6):e25670.","journal-title":"J Int AIDS Soc"},{"key":"25232_CR24","unstructured":"Australian Society for HIV, Viral Hepatitis and Sexual Health Medicine. Post-Exposure Prophylaxis after non-occupational and occupational exposure to HIV: Australian National Guidelines (Third edition) 2023. https:\/\/pep.guidelines.org.au\/wp-content\/uploads\/2023\/07\/ASHM-PEP-Guidelines_2023_3rd-edition.pdf. Accessed 8 Oct 2024."},{"key":"25232_CR25","unstructured":"HIV BASHH. UK Guideline for the use of HIV Post-Exposure Prophylaxis 2021 Post consultation version, 2023 amendment. 2021. https:\/\/www.bhiva.org\/file\/6183b6aa93a4e\/PEP-guidelines.pdf. Accessed 8 Oct 2024."},{"key":"25232_CR26","unstructured":"de Departamento HIVAIDS, Tuberculose. Hepatites Virais e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. PrEP (Profilaxia Pr\u00e9-Exposi\u00e7\u00e3o). 2022. https:\/\/www.gov.br\/aids\/pt-br\/assuntos\/prevencao-combinada\/prep-profilaxia-pre-exposicao\/prep-profilaxia-pre-exposicao. Accessed 8 Oct 2024."},{"key":"25232_CR27","unstructured":"Sant\u00e9 Andsdmdpd. Informations importantes concernant le bon usage de l\u2019emtricitabine\/t\u00e9nofovir disoproxil* dans l\u2019indication \u00abProphylaxie Pr\u00e9-Exposition (PrEP)\u00bb au VIH. 2021. https:\/\/ansm.sante.fr\/uploads\/2021\/07\/05\/emtricitabine-et-tenofovir-disoproxil-brochure-d-information-pds-version4-2021-juin.pdf. Accessed 8 Oct 2024."},{"key":"25232_CR28","unstructured":"Liu XM, Guo HS, Fan YG, Zhang Q, Liang JJ, Wei T, et al. Demand for non-occupational post-exposure prophylaxis services for HIV and associated factors among men who have sex with men in Liuzhou, Guangxi. Chin J Dis Control Prev. 2019;23(12):1517\u201322."},{"key":"25232_CR29","doi-asserted-by":"crossref","unstructured":"Huang Y, Tian R, Zhou Z, Xu J, Agins B, Zou H, et al. HIV pre-exposure prophylaxis use on a global scale among men who have sex with men: a systematic review and meta-analysis. AIDS Patient Care STDS. 2023;37(4):159\u201391.","DOI":"10.1089\/apc.2022.0198"},{"key":"25232_CR30","unstructured":"AIDS and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association. Chinese center for disease control and Prevention. Chinese guidelines for diagnosis and treatment of HIV\/AIDS (2021 edition). Zhonghua Nei Ke Za Zhi. 2021;60(12):1106\u201328."},{"key":"25232_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/27550834231214958","volume":"7","author":"M Magnus","year":"2023","unstructured":"Magnus M, Yellin H, Langlands K, Balachandran M, Turner M, Jordan J, et al. Overcoming structural barriers to diffusion of HIV pre-exposure prophylaxis. The Journal of Medicine Access. 2023;7:27550834231214958.","journal-title":"The Journal of Medicine Access"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25232-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:41:23Z","timestamp":1763448083000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25232-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25232"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25232-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Guangxi Medical University (No. 20210173). All the participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3974"}}